Article: Patient-Centered Decision-Making in Metastatic Breast Cancer Care Delivery: A Call to Action
Rozanne Wilson and her co-authors talk about the “call to action” to elevate the critical components of Patient-Centered Decision-Making and what that looks like in this month’s JNCCN article.
Charline Shan Named on MM+M’s 2024 Women to Watch List
We’re thrilled to announce that Charline Shan, Vice President of Strategic Consulting, has been named on MM+M’s 2024 Women to Watch list! A pharmacist turned strategic powerhouse, Charline excels at decoding the complex web of value in healthcare, shaping pre-launch success, and championing women in the industry.
Video: Cardiac Disease Prevention
While statins have transformed cardiovascular disease prevention, patients with a lesser-known type of lipid disease called elevated lipoprotein(a) (Lp[a]) face unique challenges. Recent clinical trials exploring Lp(a)-targeting medications show promise, yet proactive screening practices vary. Cynthia Miller, MD, MPH, FACP, Vice President, Medical Director, sits down with DocWire News and shares insights on the significance of early Lp(a) screening, strategies to enhance preventative cardiology, and optimize patient care.
Access90: Inflation Reduction Act Insights Series – Patient Affordability A Key Question Answered
The Inflation Reduction Act will increase drug affordability—but that money comes from somewhere. Ryan Cox, VP, Director, PRECISIONvalue Access Experience Team, discusses the unintended consequences for payers, biopharmaceuticals—and the future of patient’s drug choices. Learn more in this video.
Precision March Events Calendar
The PV&H March Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Article: Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward With Dr. Jason Mouabbi, Dr. Ross Maclean, and Michael Glover
Accelerated FDA approvals are under scrutiny and at the center of many debates. Explore the complexities, benefits, and risks of accelerated approvals with Ross Maclean, EVP at PRECISIONheor & Head of Medical Affairs at Precision Value & Health, in an insightful discussion alongside Dr. Jason A. Mouabbi, Breast Medical Oncologist at MD Anderson.
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors’ inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life.
The firm secured rankings in four distinct categories:
- Vault Consulting 50 North America
- Best Boutique Consulting Firms
- Best Consulting Firms for Women
- Best Consulting Firms for Formal Training
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Article: Tight-Knit Patient Communities Open Their Doors to Pharma
The rules of engagement for patient and caregiver communities have changed. Once off limit to industry insiders, patient communities are now opening their doors to pharma. What does this mean for pharma companies and how do you shift your strategy? Jack DeManche, Director of Digital Strategy at PRECISIONeffect, chats with MM+M and other industry leaders about the catalysts driving the shift towards greater community engagement, insights into the evolving landscape of patient involvement, and nuanced approaches to fostering collaborations.
